Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes

Journal of Pharmaceutical Sciences

Volumn 95, Issue 10, 2006, Pages 2246-2255

  Buchanan, Charles M ^a   Buchanan, Norma L ^a   Edgar, Kevin J ^a   Lambert, Juanelle L ^a   Posey Dowty, Jessica D ^a   Ramsey, Michael G ^a   Wempe, Michael F ^a  

^a EASTMAN CHEMICAL COMPANY   (United States)

Author keywords

Complex; Dissolution; HBenBCD; Hydroxybutenyl cyclodextrin; Liquid fill; Solubility; Tamoxifen

Indexed keywords

4 HYDROXYTAMOXIFEN; CYCLODEXTRIN DERIVATIVE; DRUG METABOLITE; HYDROXYBUTENYL BETA CYCLODEXTRIN; NORTAMOXIFEN; TAMOXIFEN; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG DEGRADATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUBSTITUTION REACTION; ULTRAVIOLET SPECTROSCOPY;

EID: 33750027706     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20710     Document Type: Article

References (25)

1. Furr BJA, Jordan VC. 1984. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25:127-205.
2. Park WC, Jordan VC. 2002. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med 8:82-88.
3. Tamoxifen citrate (Nolvadex®) product label. www.fda.gov.
4. Toivola RJ, Karjalainen AJ, Kurkela KOA, Soderwall ML, Kangas LVM, Blanco GL, Sunduiqst HK. 1987. Novel tri-phenyl alkane and alkene derivatives and their preparation and use. US Patent 4,696,949.
5. Yalkowsky SH. 1999. Solubility and solubilization in aqueous media. NY: Oxford University Press.
6. Harper MJK, Walpole AL. 1967. A new derivative of triphenylethylene: Effect of implantation and mode of action in rats. J Reprod Fert 13:101-119.
7. Harper MJK, Walpole AL. 1966. Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes. Nature 212:87.
8. Connors KA. 1997. The stability of cyclodextrin complexes in solution. Chem Rev 97:1325-1357.
9. Szejtli J. 1995. Selectivity/structure correlation in cyclodextrin chemistry. Supramol Chem 6:217-223.
10. Uekama K, Hirayama F, Irie T. 1998. Cyclodextrin drug carrier systems. Chem Rev 98:2045-2076.
11. Szejtli J. 1991. Cyclodextrins in drug formulations: Part II. Pharm Technol 15:24-38.
12. Loftsson T, Fridriksdottir H, Olafsdottir BJ, Gudmundsson O. 1991. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharmaceutica Nordica 3:215-217.
13. Redenti E, Szente L, Szejtli J. 2000. Drug/cyclodextrin/hydroxy acid multicomponent systems: Properties and pharmaceutical applications. J Pharma Sci 89:1-8.
14. Gerloczy A, Vikmon M, Szejtli J, Redenti E, Ventura P. 1999. Mutual solubility enhancement by binary and multicomponent complexation of clomiphene and tamoxifen. In: Labandeira JJT, Vila-Jato JL, editors. Proceedings of the International Symposium on Cyclodextrins, 9th edition. Dordrecht, The Netherlands: Kluwer Academic Publishers. pp 277-280.
15. Loftsson T, Sigurdsson HH, Masson M, Schipper N. 2004. Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs. Pharmazie 59:25-29.
16. Fischer W, Klokkers K, Sendl-Lang A. 1999. Mixture and pharmaceutical composition comprising Z-4-hydroxytamoxifen and cyclodextrin. WO 9933451.
17. Buchanan CM, Alderson SR, Cleven CD, Dixon DW, Ivanyi R, Lambert JL, Lowman DW, Offerman RJ, Szejtli J, Szente L. 2002. Synthesis and characterization of water-soluble hydroxybutenyl cyclodextrins. Carbohydr Res 327:493-507.
18. Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Malcolm MO, Ruble KM, Wacher VJ, Wempe MF. Preclinical studies involving intravenous and oral administration of these complexes to Sprague-Dawley rats have shown that these complexes provided a 10-14× increase in the oral bioavailability of tamoxifen. J Pharma Sci (in press).
19. Pan L, Ho Q, Tsutsui K, Takahashi L. 2001. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J Pharma Sci 90:521-529.
20. Chen TM, Shen H, Zhu C. 2002. Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. Comb Chem High Throughput Screen 5:575-581.
21. Buchanan CM, Buchanan NL. Unpublished results.
22. Higuchi T, Conners KA. 1965. Phase-solubility techniques. Adv Anal Chem Instr 4:117-212.
23. Thompson DO. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1-104.
24. o will significantly impact the reported binding constant.
25. The details of cyclodextrin liquid fill formulations exceed the scope of this paper and will be presented elsewhere. Buchanan CM, Buchanan NL, Lambert JL, Ramsey MG. Unpublished results.